<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Our specific aim was to assess how thrombophilic exogenous <z:chebi fb="1" ids="50114">estrogens</z:chebi> interacted with heritable <z:hpo ids='HP_0100724'>thrombophilias</z:hpo> leading to non-arteritic ischemic <z:hpo ids='HP_0001138'>optic neuropathy</z:hpo> (NAION) and <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Coagulation measures were performed in a 74 year old patient and her immediate family </plain></SENT>
<SENT sid="2" pm="."><plain>The proband had a 47 year history of 9 previous thrombotic episodes, and developed unilateral NAION 4 years after starting <z:chebi fb="0" ids="50114">estrogen</z:chebi> replacement therapy (ERT) </plain></SENT>
<SENT sid="3" pm="."><plain>The proband was heterozygous for two thrombophilic gene mutations (G20210A prothrombin gene, platelet <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> IIIa P1A1/A2 polymorphism), and homozygous for the C677T mutation in the <z:chebi fb="0" ids="25297">methylenetetrahydrofolate</z:chebi> reductase (MTHFR) gene </plain></SENT>
<SENT sid="4" pm="."><plain>Of 238 <z:mpath ids='MPATH_458'>normal</z:mpath> controls, none had these 3 gene mutations together </plain></SENT>
<SENT sid="5" pm="."><plain>The proband's mother and brother had <z:hpo ids='HP_0002625'>deep venous thrombosis</z:hpo> (DVT) </plain></SENT>
<SENT sid="6" pm="."><plain>The proband's brother, sister, nephew, daughter, and two granddaughters were homozygous for the C677T MTHFR mutation </plain></SENT>
<SENT sid="7" pm="."><plain>The proband's brother was heterozygous for the G20210A prothrombin gene mutation </plain></SENT>
<SENT sid="8" pm="."><plain>The proband's niece was heterozygous for the G20210A prothrombin gene mutation, homozygous for the C677T MTHFR mutation, homozygous for the hypofibrinolytic 4G polymorphism of the plasminogen activator inhibitor-1 (PAI-1) gene, and heterozygous for the platelet <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> IIIa P1A1/A2 polymorphism </plain></SENT>
<SENT sid="9" pm="."><plain>Of 238 <z:mpath ids='MPATH_458'>normal</z:mpath> controls, none had the niece's combination of 4 gene mutations </plain></SENT>
<SENT sid="10" pm="."><plain>When ERT-mediated <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> was superimposed on the proband's heritable <z:hpo ids='HP_0100724'>thrombophilias</z:hpo>, unilateral ischemic <z:hpo ids='HP_0001138'>optic neuropathy</z:hpo> developed, her tenth thrombotic event over a 5 decade period </plain></SENT>
<SENT sid="11" pm="."><plain>When <z:chebi fb="0" ids="50114">estrogen</z:chebi>-<z:chebi fb="0" ids="50745">progestin</z:chebi> oral contraceptives were given to the proband's niece, she had an <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> at age 22 </plain></SENT>
<SENT sid="12" pm="."><plain>Exogenous <z:chebi fb="0" ids="50114">estrogen</z:chebi>-mediated <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> superimposed on heritable <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> and hypofibrinolysis is associated with arterial and venous <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e>, and appears to be a preventable, and potentially reversible etiology for ischemic <z:hpo ids='HP_0001138'>optic neuropathy</z:hpo> and <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
</text></document>